Entrectinib for treating NTRK fusion-positive solid tumours in people 12 years and over (terminated appraisal)

  • Technology appraisal
  • TA1118
  • Published: 

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence